GLASGOW, Scotland, September 3 /PRNewswire/ --

Leading neurosurgical device developer Elekta will feature the newest
advances in neurosurgical diagnostic and treatment devices, along with
clinical workflow solutions that make neurosurgery more effective and
efficient at the European Association of Neurosurgical Societies (EANS)
European Congress September 2-7, 2007. More than 1,000 neurosurgeons and
related medical professionals will gather at the Scottish Exhibition &
Conference Centre in Glasgow for the event.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGO )

Leksell Gamma Knife(R) Perfexion(TM) highlighted

Positioned at the entrance of the exhibition hall, Elekta will feature
Leksell Gamma Knife(R) Perfexion(TM), a quantum leap in stereotactic
radiosurgery. The revolutionary patented design of the new Leksell Gamma
Knife Perfexion collimator system dramatically expands treatment reach,
simplifying the process of treating multiple tumors in the same session.
Leksell Gamma Knife Perfexion provides better dosimetry performance than any
other competitive radiosurgical system currently on the market and is
estimated to increase the number of patients that can benefit from Gamma
Knife surgery by up to 40 percent.

In addition, Gamma Knife(R) surgery is a radiosurgical procedure that is
specifically well suited for the treatment of brain metastases.

"Leksell Gamma Knife Perfexion offers brain metastasis treatment in less
time than other radiosurgical devices. Feedback from the first users in
France, the United Kingdom and the United States has been overwhelmingly
positive. Professor Jean Regis, La Timone Hospital in Marseilles has
published that it is possible to treat four brain metastases eccentrically
located (frontal anterior, far lateral and posterior fossa) in less than two
hours," says Rolf Kjellstrom, Vice President of Sales and Marketing, Neuro &
Stereotactic Solutions, Elekta. "It treats brain tumors very efficiently, and
because the treatment is non-invasive, patient recovery time is nonexistent
or dramatically reduced compared with invasive surgery."

David A. Larson, M.D., Ph.D., Radiation Oncologist and Co-Medical
Director at the Gamma Knife Program, Washington Hospital, adds, "Our
increasing ability to control primary cancers creates increased urgency to
detect and treat metastatic lesions. Naturally, we want to do so
non-invasively when possible and with a resulting positive impact on quality
of life. Leksell Gamma Knife Perfexion, a remarkably sophisticated
instrument, can safely and efficiently radiate multiple targets in a single
session, and will surely benefit many patients."

New Linux-based software makes workflow more efficient and saves cost

Also on display will be Elekta neurosurgery workflow solutions, including
Leksell SurgiPlan(R), Elekta's advanced image-based neurosurgical planning
software, and GammaPlan(R) PFX(TM), a treatment planning system with remote
capabilities that provides all the tools needed to make full use of the
enhanced features of Leksell Gamma Knife Perfexion. Leksell SurgiPlan and
Leksell GammaPlan are now Linux-based for more efficient workflow and lower
cost to hospitals and clinics. Leksell SurgiPlan also has a new module for
pre-planning, which enables flexible planning of procedures, and automatic
optimization of image quality.

Elekta Neuromag(R) system provides real-time MEG brain mapping with high
spatial resolution

Elekta also will be exhibiting Elekta Neuromag(R), an advanced device for
performing magnetoencephalography (MEG). With a MEG system, neurosurgeons,
neurologists and other specialists are able to non-invasively register nerve
cell activity in the brain in real time. The technology is used routinely for
pre-surgical mapping and epilepsy investigations as well as in clinical
research. Elekta Neuromag features the highly innovative and unique
MaxFilter(TM) software that filters all magnetic interferences and artefacts,
providing an analysis with more reliable data.

Elekta Neuromag(R) 306 MEG channels sensor array has higher density than
any other system on the market, providing a better representation of brain
activity than any other MEG system.

MEG offers functional mapping information and measurement of brain
activity in real time with high spatial resolution, unlike Computer
Tomography (CT) and Magnetic Resonance Imaging (MRI and fMRI), which only
provide structural, anatomical, metabolic and indirect functional
information.

Elekta committed to advanced neurosurgery solutions

Elekta, known as the pioneer and world leader in stereotactic
neurosurgery, continues to widen the gap between itself and other medical
technology companies with the development of advanced tools for precision
cancer treatment. "Elekta offers the complete spectrum of stereotactic
devices," says Kjellstrom, "and Elekta's commitment to innovation in
neurosurgery is unmatched."

About Elekta

Elekta is an international medical-technology Group, providing meaningful
clinical solutions, comprehensive information systems and services for
improved cancer care and management of brain disorders. All of Elekta's
solutions employ non-invasive or minimally invasive techniques and are
therefore clinically effective, gentle on the patient and cost-effective.

Clinical solutions include, among others, Leksell Gamma Knife(R) product
line for non-invasive treatment of brain disorders, Elekta Axesse(TM) for
Image guided Stereotactic treatments, and Elekta Synergy(R) for intensity
modulated radiation therapy (IMRT) and image guided radiation therapy (IGRT).
Following the acquisition of IMPAC Medical Systems Inc. in April 2005, the
Elekta Group became the world's largest supplier of oncology software.

Elekta's systems and solutions are used at over 4,000 hospitals around
the world to treat cancer and manage clinical operations as well as to
diagnose and treat brain disorders, including tumors, vascular malformations
and functional disorders.

With approximately 2,000 employees, Elekta's corporate headquarters is
located in Stockholm, Sweden and the company is listed on the Stockholm Stock
Exchange under the ticker EKTAb. For more information about Elekta, please
visit www.elekta.com.

Web site: http://www.elekta.com